prednisone Archives - Medical Conferences

Is avacopan better than prednisone for respiratory ANCA-associated vasculitis outcomes?

Presented By

Prof. Ulrich Specks, Mayo Clinic, MN, USA

Trial

Phase 3, ADVOCATE

Conference

ATS 2022

18 July, 2022 11:56

Significant tumour response to neoadjuvant therapy in high-risk non-metastatic prostate cancer

Presented By

Prof. Neil Fleshner, Princess Margaret Cancer Centre, Canada

Trial

Phase 2, ACDC-RP

Conference

ASCO GU 2022

8 April, 2022 11:22

Addition of abiraterone to ADT/docetaxel does not increase bone loss

Presented By

Dr Guilhem Roubaud, Institut Bergonié, France

Trial

Phase 3, PEACE-1

Conference

ASCO GU 2022

8 April, 2022 11:21

POLARIX: Novel regimen superior to R-CHOP in DLBCL

Presented By

Prof. Hervé Tilly, University of Rouen, France

Trial

Phase 3, POLARIX

Conference

ASH 2021

4 February, 2022 10:56

ASH 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

ASH 2021

4 January, 2022 08:00

Both men with high-risk non-metastatic prostate cancer and men with metastatic prostate cancer benefit from intensified hormone treatment

Trial

Phase 3, PEACE-1, STAMPEDE, ARCHES

Conference

ESMO 2021

19 November, 2021 09:27

Apalutamide prolongs progression-free survival in prostate cancer

Presented By

Dr Dana Rathkopf, Memorial Sloan Kettering Cancer Center, New York, USA

Trial

Phase 3, ACIS

Conference

ASCO GU 2021

24 March, 2021 14:49

ALCYONE: New overall survival results for myeloma

Presented By

Dr Maria Victoria Mateos, University Hospital of Salamanca, Spain

Trial

Phase 3, ALCYONE

Conference

ASH 2019

5 March, 2020 16:16

Prolonged remission after stop of tocilizumab for patients with giant cell arteritis

Presented By

Prof. John H. Stone, Harvard Medical School, Boston, USA

Trial

Phase 3, GiACTA

Conference

ACR 2019

4 February, 2020 10:19

Tapering of prednisone in RA patients who achieved low disease activity or remission with tocilizumab

Presented By

Prof. Gerd Burmester, Free University and Humboldt University of Berlin, Germany

Conference

EULAR 2019

4 September, 2019 16:56

Bruton’s tyrosine kinase inhibitor highly effective in pemphigus vulgaris

Presented By

Prof. Dedee Murrell, University of New South Wales, Australia

Conference

AAD 2019

19 April, 2019 15:36